Morris Charles Q 4
4 · LAVA Therapeutics NV · Filed Feb 18, 2025
Insider Transaction Report
Form 4
Morris Charles Q
Chief Medical Officer
Transactions
- Award
Share Options (Right to Buy)
2025-02-13+130,850→ 130,850 totalExercise: $0.93Exp: 2035-03-12→ Common Shares (130,850 underlying)
Footnotes (1)
- [F1]The shares underlying the option vest in 48 equal monthly installments beginning on March 13, 2025, provided the Reporting Person remains in a service relationship with the Issuer or a subsidiary of the Issuer on each such vesting date.